Neutralization, effector function and immune imprinting of Omicron variants.
Saved in:
| Title: | Neutralization, effector function and immune imprinting of Omicron variants. |
|---|---|
| Authors: | Addetia A; Department of Biochemistry, University of Washington, Seattle, WA, USA., Piccoli L; Humabs BioMed, Bellinzona, Switzerland., Case JB; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Park YJ; Department of Biochemistry, University of Washington, Seattle, WA, USA., Beltramello M; Humabs BioMed, Bellinzona, Switzerland., Guarino B; Humabs BioMed, Bellinzona, Switzerland., Dang H; Vir Biotechnology, San Francisco, CA, USA., de Melo GD; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Pinto D; Humabs BioMed, Bellinzona, Switzerland., Sprouse K; Department of Biochemistry, University of Washington, Seattle, WA, USA., Scheaffer SM; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Bassi J; Humabs BioMed, Bellinzona, Switzerland., Silacci-Fregni C; Humabs BioMed, Bellinzona, Switzerland., Muoio F; Humabs BioMed, Bellinzona, Switzerland., Dini M; Humabs BioMed, Bellinzona, Switzerland., Vincenzetti L; Humabs BioMed, Bellinzona, Switzerland., Acosta R; Vir Biotechnology, San Francisco, CA, USA., Johnson D; Vir Biotechnology, San Francisco, CA, USA., Subramanian S; Vir Biotechnology, San Francisco, CA, USA., Saliba C; Humabs BioMed, Bellinzona, Switzerland., Giurdanella M; Humabs BioMed, Bellinzona, Switzerland., Lombardo G; Humabs BioMed, Bellinzona, Switzerland., Leoni G; Humabs BioMed, Bellinzona, Switzerland., Culap K; Humabs BioMed, Bellinzona, Switzerland., McAlister C; Vir Biotechnology, San Francisco, CA, USA., Rajesh A; Vir Biotechnology, San Francisco, CA, USA., Dellota E Jr; Vir Biotechnology, San Francisco, CA, USA., Zhou J; Vir Biotechnology, San Francisco, CA, USA., Farhat N; Vir Biotechnology, San Francisco, CA, USA., Bohan D; Vir Biotechnology, San Francisco, CA, USA., Noack J; Vir Biotechnology, San Francisco, CA, USA., Chen A; Vir Biotechnology, San Francisco, CA, USA., Lempp FA; Vir Biotechnology, San Francisco, CA, USA., Quispe J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Kergoat L; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Larrous F; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Cameroni E; Humabs BioMed, Bellinzona, Switzerland., Whitener B; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Cippà P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland., Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland., Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Franzetti-Pellanda A; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Biggiogero M; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Zappi S; Division of Nephrology, Cantonal Hospital Aarau, Aarau, Switzerland., Bernasconi L; Institute of Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland., Kim MJ; Division of Nephrology, Cantonal Hospital Aarau, Aarau, Switzerland., Rosen LE; Vir Biotechnology, San Francisco, CA, USA., Schnell G; Vir Biotechnology, San Francisco, CA, USA., Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA., Benigni F; Humabs BioMed, Bellinzona, Switzerland., Franko N; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Logue JK; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Yoshiyama C; Department of Biochemistry, University of Washington, Seattle, WA, USA., Stewart C; Department of Biochemistry, University of Washington, Seattle, WA, USA., Chu H; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Bourhy H; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France., Schmid MA; Humabs BioMed, Bellinzona, Switzerland., Purcell LA; Vir Biotechnology, San Francisco, CA, USA., Snell G; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs BioMed, Bellinzona, Switzerland., Diamond MS; Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu., Corti D; Humabs BioMed, Bellinzona, Switzerland. dcorti@vir.bio., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA. dveesler@uw.edu.; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA. dveesler@uw.edu. |
| Source: | Nature [Nature] 2023 Sep; Vol. 621 (7979), pp. 592-601. Date of Electronic Publication: 2023 Aug 30. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
